Inventor · disambiguated record
Ying-Ping Jiang
Also filed as: JIANG YING · JIANG YING-PING
17 granted patents·8 pending applications·160 citations·filing 2001–2022
90Inventor score
Files withCELLERANT THERAPEUTICS INC5JIANG YING2KAUVAR LAWRENCE M2RIGEL PHARMACEUTICALS INC2SCHERING CORP2
Top patents by PatentIndex Score
25 records- 0196US8841418B2Antibodies that specifically bind to TIM3KARSUNKY HOLGER·Filed 2012·Granted Sep 23, 2014·141 cites·9 claims
- 0294US9631026B2Antibodies that specifically bind to TIM3CELLERANT THERAPEUTICS INC·Filed 2014·Granted Apr 25, 2017·15 cites·12 claims
- 0385US11072662B2Humanized anti-CLL-1 antibodiesCELLERANT THERAPEUTICS INC·Filed 2016·Granted Jul 27, 2021·2 cites·12 claims
- 0475US11359025B2Anti-IL1-RAP antibodiesCANTARGIA AB·Filed 2017·Granted Jun 14, 2022·1 cites·17 claims
- 0567US9017668B2High affinity human antibodies to human cytomegalovirus (CMV) gB proteinKAUVAR LAWRENCE M·Filed 2011·Granted Apr 28, 2015·1 cites·10 claims
- 0664US10301394B2Antibodies that specifically bind to TIM3CELLERANT THERAPEUTICS INC·Filed 2017·Granted May 28, 2019·0 cites·14 claims
- 0762US7807390B2G-protein coupled receptor ligands and methodsSCHERING CORP·Filed 2008·Granted Oct 5, 2010·0 cites·17 claims
- 0858US2015152476A1Reagents and methods for direct labeling of nucleotidesMARKER GENE TECHNOLOGIES INC·Filed 2014·Application pending·0 cites
- 0957US2023416839A1Method for detecting human microsatellite instability site, and use thereofHUANG XIN·Filed 2022·Application pending·0 cites
- 1055US10030069B2High affinity human antibodies to human cytomegalovirus (CMV) gB proteinTRELLIS BIOSCIENCE LLC·Filed 2017·Granted Jul 24, 2018·0 cites·12 claims
- 1154US8133980B2Antibodies and functional fragments thereof that specifically bind an RF-amide peptide or a precursor thereofJIANG YING·Filed 2010·Granted Mar 13, 2012·0 cites·9 claims
- 1254US7338772B2G-protein coupled receptor ligands and methodsSCHERING CORP·Filed 2003·Granted Mar 4, 2008·0 cites·27 claims
- 1354US2014087402A1Synthetic luciferase gene and proteinMarker Gene Technologies·Filed 2012·Application pending·0 cites
- 1451US7521192B2EDG: modulators of lymphocyte activation and migrationRIGEL PHARMACEUTICALS INC·Filed 2001·Granted Apr 21, 2009·0 cites·23 claims
- 1550US8916346B2Reagents and methods for direct labeling of nucleotidesNALEWAY JOHN J·Filed 2011·Granted Dec 23, 2014·0 cites·1 claims
- 1649US9688744B2High affinity human antibodies to human cytomegalovirus (CMV) GB proteinTRELLIS BIOSCIENCE LLC·Filed 2015·Granted Jun 27, 2017·0 cites·17 claims
- 1749US2008260719A1EDG: Modulators of lymphocyte activation and migrationRIGEL PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 1847US2015315279A1Antibodies that bind membrane-bound il1rapCELLERANT THERAPEUTICS INC·Filed 2013·Application pending·0 cites
- 1946US8450054B2Modified Luciola cruciata luciferase gene and proteinJIANG YING·Filed 2010·Granted May 28, 2013·0 cites·12 claims
- 2046US2007179094A1Modulation of MDL-1 activity for treatment of inflammatory diseaseBAYER SCHERING PHARMA AG·Filed 2007·Application pending·0 cites
- 2144US10786527B2Nanoparticle-stabilized nanocapsules and methods of preparation and use for nucleic acid deliveryUNIV MASSACHUSETTS·Filed 2016·Granted Sep 29, 2020·0 cites·17 claims
- 2241US12352752B2Application of Niemann-Pick C1 protein in diagnosis and treatment of cancerACAD OF MILITARY MEDICAL SCIENCES·Filed 2018·Granted Jul 8, 2025·0 cites·4 claims
- 2340US2018312592A1Cysteine-substituted immunoglobulinsCELLERANT THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 2439US10676520B2Antibodies useful in passive influenza immunizationKAUVAR LAWRENCE M·Filed 2011·Granted Jun 9, 2020·0 cites·15 claims
- 2536US2004253647A1Cell-based high-throughput screening methodsFiled 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ying-Ping Jiang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →